WertQ1, 26Gesamtverbindlichkeiten110.94 MGesamtkapital514.8 MGesamtverbindlichkeiten und Eigenkapital625.74 MGesamtverschuldung—Nettoverschuldung—
Generate Biomedicines, Inc. - Common Stock
Generate:Biomedicines is a biotechnology company founded in 2018 and headquartered in Somerville, Massachusetts. It specializes in using machine learning to design and optimize proteins for therapeutic applications, with a focus on immunology, oncology, and infectious diseases.